People

The CRG investment team leverages more than 175 years of collective and complementary experience across healthcare, private equity, capital markets, and operations to deliver the most innovative structures to meet the capital needs of our financing partners.

Nathan Hukill is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen

Nate Hukill

Managing PartnerPartner, Piedmont Evergreen

Nathan Hukill is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen. Mr. Hukill oversees all aspects of the investment process, including investment sourcing, due diligence, portfolio construction and portfolio management. Mr. Hukill also oversees the investor relations process, including fund raising, reporting and limited partner relationship management. CRG’s accounting, finance, compliance and legal teams also report to Mr. Hukill.

Mr. Hukill joined CRG in 2009 to implement investment strategies he had uncovered while beginning his investment career at Salomon Smith Barney, where he managed a portfolio of approximately $800 million, and Highland Capital Management, where he invested and managed approximately $4.5 billion of healthcare credit assets.

Mr. Hukill graduated Phi Beta Kappa, summa cum laude from the University of Colorado at Boulder in 1999 with a Bachelor of Science in business administration. He received an M.B.A. from the Darden Graduate School of Business at the University of Virginia in 2005. Mr. Hukill is a former professional cyclist who had the unique challenge of first competing against Lance Armstrong when they were both 16 years old.

Luke Düster is a member of CRG’s Founders Group and serves as Partner and member of CRG’s investment committee.

Luke Düster

Partner

Luke Düster is a member of CRG’s Founders Group and serves as Partner and member of CRG’s investment committee. Mr. Düster leads CRG’s investment process from sourcing and due diligence through realization. He is also responsible for portfolio management and portfolio company exits. Mr. Düster also serves on the board of directors of several CRG portfolio companies, both as a director and as an observer, and serves portfolio company senior management teams as an advisor on financial, strategic and operational initiatives. He has led investments in companies such as Neotract, Nevro, Omeros, Synergy Pharmaceuticals, Strongbridge Biopharma, Silk Road Medical, NanoString Technologies and many others.

Prior to CRG, Mr. Düster was an investment banker at Harris Williams & Co., where he advised private equity and corporate clients across a broad range of M&A assignments. Mr. Düster also held investment banking roles at the Wallach Company, a regional investment banking boutique, and at the Nord Companies, a healthcare advisory firm.

Mr. Düster received a bachelor’s degree from the University of Colorado at Boulder in 1997, where he graduated summa cum laude. He received an M.B.A with honors from the Wharton School at the University of Pennsylvania in 2004.

Michael Weinmann is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen and member of CRG’s investment committee.

Mike Weinmann

PartnerPartner, Piedmont Evergreen

Michael Weinmann is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen and member of CRG’s investment committee. Mr. Weinmann joined CRG in 2009 and has 18 years of capital markets and investing experience. Mr. Weinmann has responsibility for the firm’s capital raising activities, including raising equity and debt capital on behalf of the firm’s managed funds. During his time with CRG, Mr. Weinmann has helped the firm raise more than $3 billion in capital, including CRG’s first-ever Asset-Backed Securities debt financings.

Prior to joining CRG, Mr. Weinmann worked as an Executive Director in Morgan Stanley’s Global Capital Markets division, specializing in healthcare debt financings and intellectual property monetizations. Over the course of his career, Mr. Weinmann has closed in excess of $20 billion of debt and equity financings and an additional $10 billion of M&A transactions.

Mr. Weinmann received a Bachelor of Science in chemical engineering in 1999 from the Johns Hopkins University, graduating first in a class of 770.

David Carter is a member of CRG’s Founders Group and serves as Partner. Mr. Carter joined CRG in 2003 and has more than 25 years of investment and advisory experience.

David Carter

Partner

David Carter is a member of CRG’s Founders Group and serves as Partner. Mr. Carter joined CRG in 2003 and has more than 25 years of investment and advisory experience. Mr. Carter leads the due diligence efforts related to CRG’s investments in the medical device, specialty pharma, drug delivery, biopharma and tools & diagnostic sectors. Mr. Carter, in addition to focusing on sourcing, execution and monitoring existing CRG investments is responsible for staffing CRG deal teams. Prior to joining CRG, Mr. Carter was a partner at Palestra Capital, a hedge fund focused on risk arbitrage and special situations. Before joining Palestra, Mr. Carter was a high yield analyst at Furman Selz LLC, where he was responsible for coverage of healthcare-related high yield debt. Previously, Mr. Carter was an investment banking analyst in the Healthcare Group at Chemical Bank and a research assistant in the Mergers & Acquisitions Group of Morgan Stanley. Over the course of his career, Mr. Carter has closed in excess of $5 billion of financing activity.

Mr. Carter received a Bachelor of Science in finance from The Pennsylvania State University in 1988. He received a Master of Arts degree in information science and systems in 1994 and an M.B.A. in 1996, both from Columbia University.

Andrei Dorenbaum is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen and General Counsel.

Andrei Dorenbaum

General CounselPartner, Piedmont Evergreen

Andrei Dorenbaum is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen and General Counsel. Mr. Dorenbaum joined CRG in 2010 and is responsible for managing the legal function of the firm’s investment and financing activities. This includes structuring investments, identifying underwriting risks during diligence and negotiating terms. In addition, he supports the structuring and negotiation of the funds’ financing facilities with banks and other financing counter parties. He is also responsible for managing bankruptcies and contested workouts. Mr. Dorenbaum manages operations in the Houston office and oversees the operation of CRG’s back-office and accounting group. Prior to joining CRG, Mr. Dorenbaum was an assistant general counsel at Highland Capital where he completed over $2 billion in negotiated investments and structured derivative financing arrangements.

Mr. Dorenbaum received a B.A. (magna cum laude) in applied economics and J.D. (cum laude) both from the University of Michigan. He also earned an LL.M. from Georgetown University School of Law.

Garth Monroe joined CRG in March 2014 as Chief Financial Officer. He is responsible for accounting, tax, treasury, human resources, information technology, and risk management.

Garth Monroe

Chief Financial Officer

Garth Monroe joined CRG in March 2014 as Chief Financial Officer. He is responsible for accounting, tax, treasury, human resources, information technology, and risk management. Keeping pace with CRG’s growth, the accounting team has expanded from two to six professionals during his tenure. The team produces quarterly financial statements, annual federal and state tax returns, K-1s, and answers LP requests.

Prior to joining the firm, he was Vice President and CFO at both BioNano Genomics and Epocal, two early-stage biotechnology companies. Mr. Monroe started his career working for United Technologies and JetBlue Airways; he also served in the U.S. Marine Corps.

Mr. Monroe is a CPA (inactive), and graduated summa cum laude from the University of Connecticut with a Bachelor of Science in Business Administration. He earned an MBA from the University of Virginia, Darden School of Business.

Scott Li joined CRG in 2015 and is a Managing Director. Mr. Li has been focused on the healthcare industry as an advisor, investor and executive for over 15 years.

Scott Li

Managing Director

Scott Li joined CRG in 2015 and is a Managing Director. Mr. Li has been focused on the healthcare industry as an advisor, investor and executive for over 15 years. Mr. Li helps leads investment sourcing, diligence, and execution for CRG activity in various sectors, including healthcare services and specialty pharma.

Prior to joining CRG, Mr. Li was an investment banker with Hammond Hanlon Camp LLC (“H2C”). Mr. Li’s previous investment banking experience also includes positions in the Life Sciences Investment Banking Group of Lazard and the North American M&A Group of J.P. Morgan. Prior to joining H2C, Mr. Li was the Chief Financial Officer of pingmd, a provider of an online communication platform for primary care physicians. Mr. Li was also previously an Associate with ABS Ventures, the venture capital arm of DB Capital Partners. Mr. Li. received an AB in economics from Princeton University in 1997 and an M.B.A from the Wharton School at the University of Pennsylvania in 2004.

Todd Holmes joined CRG in 2018 and serves as a Principal. Todd brings to CRG nearly 15 years of investing, company building and transaction experience across private and public sectors.

Todd Holmes

Principal

Todd Holmes joined CRG in 2018 and serves as a Principal. Todd brings to CRG 15 years of investing, company building and transaction experience across private and public sectors. Mr. Holmes leads investment sourcing, diligence and execution for CRG activity in various sectors including specialty pharma, medical technology and healthcare services.

Prior to joining CRG, Todd was an investor and founding member of Gurnet Point Capital. There he led investments and acquisitions across multiple stages and sectors within healthcare and was actively involved on company boards as well as in portfolio company operations.

Previously, Mr. Holmes was a member of Third Rock Ventures where he held investment and operational roles and was part of the founding team at Ember Therapeutics. Earlier in his career, Todd was an investor at BVF Partners, a biotechnology-focused hedge fund, and a member of the commercial lending practice at Silicon Valley Bank.

Mr. Holmes received a Bachelor's degree in Economics from Colgate University and an MBA from the Wharton School at the University of Pennsylvania.

Adam Whitehead joined CRG in 2016, bringing over 10 years of experience in asset allocation, manager due diligence and fundraising.

Adam Whitehead

Vice President

Adam Whitehead joined CRG in 2016, bringing over 10 years of experience in asset allocation, manager due diligence and fundraising. Mr. Whitehead is part of CRG’s Investor Relations team, responsible for raising capital and client service. Previously, Mr. Whitehead was a senior investment analyst at Crestone Capital Advisors, a large multi-family office. Mr. Whitehead has held research and trading roles at Quantitative Equity Systems, Sovereign Wealth Management, Warwick Capital Management, The Bornhoft Group and Branch Banking & Trust.

Mr. Whitehead graduated from St. Andrews Presbyterian College, magna cum laude, in Laurinburg, North Carolina with a major in business (emphasis in finance and accounting).

Zain Shekhani joined CRG in 2013 and is a member of the Investment Team. Mr. Shekhani’s focuses include identifying and assessing new investment opportunities, due diligence efforts before making...

Zain Shekhani

Vice President

Zain Shekhani joined CRG in 2013 and is a member of the Investment Team. Mr. Shekhani’s focuses include identifying and assessing new investment opportunities, due diligence efforts before making portfolio companies investments, and servicing and monitoring portfolio companies post-investment. Additionally, Mr. Shekhani supports the firm’s investor relations and capital raising efforts. Prior to CRG, Mr. Shekhani was an analyst with Stifel's Healthcare Investment Banking Group.

Mr. Shekhani graduated magna cum laude from the Stern School of Business at New York University with a Bachelor of Science in Finance and Economics.

Kevin Reilly joined CRG in 2014 and is a member of the Investment Team. Mr. Reilly’s primary focus is identifying and assessing new investment opportunities, due diligence efforts before making...

Kevin Reilly

Vice President

Kevin Reilly joined CRG in 2014 and is a member of the Investment Team. Mr. Reilly’s primary focus is identifying and assessing new investment opportunities, due diligence efforts before making portfolio companies investments, and servicing and monitoring portfolio companies post-investment. Mr. Reilly has been particularly active within medical devices, amongst other healthcare sectors. Mr. Reilly also spends time on the capital-raising side of the business including helping to manage CRG’s leverage strategy. Prior to CRG, Mr. Reilly was an analyst with Stifel’s Healthcare Investment Banking Group.

Mr. Reilly graduated from the Robert H. Smith School of Business at the University of Maryland with a Bachelor of Science in Finance and Information Systems.

Kris Talgo joined CRG in 2015 and serves as an Associate on the Investment Team.

Kris Talgo

Associate

Kris Talgo joined CRG in 2015 and serves as an Associate on the Investment Team. Mr. Talgo’s primary focus is identifying and assessing new investment opportunities, due diligence efforts before making portfolio company investments, and servicing and monitoring portfolio companies post-investment. Mr. Talgo has focused largely within specialty pharmaceuticals and biopharmaceuticals, amongst other healthcare sectors. Prior to CRG, Mr. Talgo was an analyst with Leerink Partners’ Investment Banking Group.

Mr. Talgo graduated with honors from Lehigh University with a Bachelor of Science in Finance and Accounting.

Stanley Twarog joined CRG in 2016 and serves as an Associate on the Investment Team.

Stanley Twarog

Associate

Stanley Twarog joined CRG in 2016 and serves as an Associate on the Investment Team. Mr. Twarog’s primary focuses are identifying, assessing, and executing new investment opportunities as well as monitoring existing portfolio investments. Prior to CRG, Mr. Twarog served in a financial operations role at Surgical Care Affiliates, a leading outpatient ambulatory surgical care company. Prior to joining Surgical Care Affiliates, Mr. Twarog was an analyst at Hammond Hanlon Camp, a healthcare focused strategic advisory and investment banking firm.

Mr. Twarog graduated cum laude from Vanderbilt University with a B.A. in Economics.

Noah Putter joined CRG in 2016 and serves as an Analyst on the Investment Team.

Noah Putter

Analyst

Noah Putter joined CRG in 2016 and serves as an Analyst on the Investment Team. Mr. Putter’s primary focuses are identifying, assessing, and executing new investment opportunities as well as monitoring existing portfolio investments. Mr. Putter also works on executing CRG’s leverage strategy, helping to raise and manage debt financing at the fund level. Prior to CRG, Mr. Putter was an analyst with Leerink Partners’ Investment Banking Group.

Mr. Putter graduated with high distinction from the University of Michigan’s Ross School of Business with a Bachelor of Business Administration

Ben Wessner joined CRG in 2017 and serves as an Analyst on the Investment Team.

Ben Wessner

Analyst

Ben Wessner joined CRG in 2017 and serves as an Analyst on the Investment Team. Mr. Wessner’s primary focuses are identifying, assessing, and executing new investment opportunities as well as monitoring existing portfolio investments. Prior to CRG, Mr. Wessner was an analyst with Piper Jaffray’s Healthcare Investment Banking Group.

Mr. Wessner graduated from the Charles H. Dyson School at Cornell University with a Bachelor of Science in Applied Economics and Management.

Ava Lee joined CRG in 2017 and serves as an Analyst on the Investor Relations team.

Ava Lee

Analyst

Ava Lee joined CRG in 2017 and serves as an Analyst on the Investor Relations team. Ms. Lee works closely with the Investments and Finance team to manage and fulfill information requests on behalf of the firm’s investors. Ms. Lee also supports the firm’s capital raising efforts through the creation of marketing materials and investor reports for current and prospective investors.

Prior to joining CRG, Ms. Lee was an Associate in Citadel's Client & Partner Group. Ms. Lee started off her career in investment banking at the Royal Bank of Canada.

Ms. Lee graduated cum laude from the University of Notre Dame with a Bachelor of Science in Finance and Political Science.

Courtney Grobe joined CRG in 2005 and serves as Vice President & Controller. Ms. Grobe’s responsibilities include overseeing the accounting and reporting of the firm’s private equity funds under...

Courtney Grobe

Vice President & Controller

Courtney Grobe joined CRG in 2005 and serves as Vice President & Controller. Ms. Grobe’s responsibilities include overseeing the accounting and reporting of the firm’s private equity funds under management, including over 20 investment vehicles and an SBIC. In addition, she manages the audit engagements and supervises two fund administrators. Prior to joining CRG, Ms. Grobe worked as an audit professional at Deloitte & Touche, where her two largest clients were in the manufacturing and healthcare industries.

Ms. Grobe graduated magna cum laude from Texas A&M University receiving a Bachelor of Business Administration, specializing in accounting. Ms. Grobe also earned a Masters degree in Accounting from Texas A&M University and is a CPA.

Erica Palestrini joined CRG in 2014 and is the Operations Manager. In addition to working with the Investor Relations Team, she supports Mr. Hukill on special projects, employee education and...

Erica Palestrini

Operations Manager & Investor Relations

Erica Palestrini joined CRG in 2014 and is the Operations Manager. In addition to working with the Investor Relations Team, she supports Mr. Hukill on special projects, employee education and training and strategic planning. Ms. Palestrini organizes and plans investment training in detection of deception and elicitation and other disciplines for CRG’s investment staff, as well as plans and manages the firm’s annual meeting of Limited Partners. Ms. Palestrini is also responsible for managing CRG’s administrative team.

Ms. Palestrini has held various operational support positions with various international companies including the Allen & Overy Law Firm in Singapore, Olswang Law Firm in London, and Air New Zealand in Auckland, New Zealand.

Colin Eckersley joined CRG in 2014 and serves as Assistant Controller. Mr. Eckersley is responsible for fund accounting, reporting, and compliance for Fund I and CRG’s SBIC.

Colin Eckersley

Assistant Controller

Colin Eckersley joined CRG in 2014 and serves as Assistant Controller. Mr. Eckersley is responsible for fund accounting, reporting, and compliance for Fund I and CRG’s SBIC. Additionally, Mr. Eckersley is in charge of the onboarding and subscription process for Fund IV. Prior to joining CRG, Mr. Eckersley held an accounting position at a small sales company.

Mr. Eckersley is a licensed CPA and graduated from the C.T. Bauer College of Business at the University of Houston with a Bachelor of Business Administration, specializing in accounting. Mr. Eckersley also earned a Masters degree in Accounting from the University of Houston.

Stephanie Divin joined CRG in 2016 and serves as Assistant Controller. Ms. Divin is responsible for the fund accounting for Funds II and Fund III.

Stephanie Divin

Assistant Controller

Stephanie Divin joined CRG in 2016 and serves as Assistant Controller. Ms. Divin is responsible for the fund accounting for Funds II and Fund III. Additionally, Ms. Divin is in charge of the compliance and reporting for the Fund II and Fund III securitization transactions and other leverage facilities. Prior to joining CRG, Stephanie worked as an assurance professional at PricewaterhouseCoopers. Stephanie was in the Private Client Service group with clients in higher education, healthcare and manufacturing.

Stephanie is a licensed CPA and graduated from the McCombs School of Business at the University of Texas with a Bachelors of Business Administration and a Masters in Professional Accountancy.

Jonathan Gay joined CRG in 2017 and serves as Senior Accountant. Mr. Gay is responsible for manager accounting and financials, accounts payable, and facilitating LP and portfolio company customer...

Jonathan Gay

Senior Accountant

Jonathan Gay joined CRG in 2017 and serves as Senior Accountant. Mr. Gay is responsible for manager accounting and financials, accounts payable, and facilitating LP and portfolio company customer service requests. Prior to joining CRG, Mr. Gay worked as an audit professional at Ernst & Young, with clients in the sports entertainment, manufacturing, and automotive industries.

Mr. Gay is a licensed CPA and graduated magna cum laude from Lamar University, with a Bachelors of Business Administration and a Masters of Science in Accounting.

Nicole Nesson joined CRG in 2015. Ms. Nesson is the Executive Assistant to Nathan Hukill and Andrei Dorenbaum.

Nicole Nesson

Executive Assistant

Nicole Nesson joined CRG in 2015. Ms. Nesson is the Executive Assistant to Nathan Hukill and Andrei Dorenbaum. Ms. Nesson also manages the day-to-day of CRG’s three office locations and coordinates internal and external client events. Prior to joining CRG she was an executive support professional at Bank of Montreal. She has held similar roles as executive assistant to the CEO of Lasco Enterprises and as office manager of credit risk software firm, Triple Point Technology.

Ashley Anderson joined CRG in 2016. Mrs. Anderson is responsible for the administrative functions for Mr. Michael Weinmann and the Investor Relations team.

Ashley Anderson

Executive Assistant

Ashley Anderson joined CRG in 2016. Mrs. Anderson is responsible for the administrative functions for Mr. Michael Weinmann and the Investor Relations team. Prior to joining CRG she was an executive assistant at JP Morgan. Mrs. Anderson supported a team of bankers in the Investment Banking group. She has held similar roles as executive assistant at Bank of America and Capital One Bank. She has over 15 years of Executive Assistance experience.

Mrs. Anderson graduated from Texas State University in San Marcos, Texas.

Abby Johnson joined CRG in 2018. Mrs. Johnson is the Executive Assistant to Luke Duster and David Carter as well as the Investment team.

Abby Johnson

Executive Assistant

Abby Johnson joined CRG in 2018. Mrs. Johnson is the Executive Assistant to Luke Duster and David Carter as well as the Investment team. Mrs. Johnson has over twelve years of Executive Assistance experience. Prior to joining CRG, Mrs. Johnson worked as an Office Manager and Executive Assistant to Bob Kagle at Benchmark Capital in San Francisco, CA. Previously, Mrs. Johnson spent nearly six years as an Executive Assistant with Masters/Thomasville & Drexel Heritage, a large, well-known furniture distributer. Additionally, Mrs. Johnson has spent extensive time living internationally in locations such as Norway and Egypt.

Nathan Hukill is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen

Nate Hukill

Managing PartnerPartner, Piedmont Evergreen

Nathan Hukill is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen. Mr. Hukill oversees all aspects of the investment process, including investment sourcing, due diligence, portfolio construction and portfolio management. Mr. Hukill also oversees the investor relations process, including fund raising, reporting and limited partner relationship management. CRG’s accounting, finance, compliance and legal teams also report to Mr. Hukill.

Mr. Hukill joined CRG in 2009 to implement investment strategies he had uncovered while beginning his investment career at Salomon Smith Barney, where he managed a portfolio of approximately $800 million, and Highland Capital Management, where he invested and managed approximately $4.5 billion of healthcare credit assets.

Mr. Hukill graduated Phi Beta Kappa, summa cum laude from the University of Colorado at Boulder in 1999 with a Bachelor of Science in business administration. He received an M.B.A. from the Darden Graduate School of Business at the University of Virginia in 2005. Mr. Hukill is a former professional cyclist who had the unique challenge of first competing against Lance Armstrong when they were both 16 years old.

Luke Düster is a member of CRG’s Founders Group and serves as Partner and member of CRG’s investment committee.

Luke Düster

Partner

Luke Düster is a member of CRG’s Founders Group and serves as Partner and member of CRG’s investment committee. Mr. Düster leads CRG’s investment process from sourcing and due diligence through realization. He is also responsible for portfolio management and portfolio company exits. Mr. Düster also serves on the board of directors of several CRG portfolio companies, both as a director and as an observer, and serves portfolio company senior management teams as an advisor on financial, strategic and operational initiatives. He has led investments in companies such as Neotract, Nevro, Omeros, Synergy Pharmaceuticals, Strongbridge Biopharma, Silk Road Medical, NanoString Technologies and many others.

Prior to CRG, Mr. Düster was an investment banker at Harris Williams & Co., where he advised private equity and corporate clients across a broad range of M&A assignments. Mr. Düster also held investment banking roles at the Wallach Company, a regional investment banking boutique, and at the Nord Companies, a healthcare advisory firm.

Mr. Düster received a bachelor’s degree from the University of Colorado at Boulder in 1997, where he graduated summa cum laude. He received an M.B.A with honors from the Wharton School at the University of Pennsylvania in 2004.

Michael Weinmann is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen and member of CRG’s investment committee.

Mike Weinmann

PartnerPartner, Piedmont Evergreen

Michael Weinmann is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen and member of CRG’s investment committee. Mr. Weinmann joined CRG in 2009 and has 18 years of capital markets and investing experience. Mr. Weinmann has responsibility for the firm’s capital raising activities, including raising equity and debt capital on behalf of the firm’s managed funds. During his time with CRG, Mr. Weinmann has helped the firm raise more than $3 billion in capital, including CRG’s first-ever Asset-Backed Securities debt financings.

Prior to joining CRG, Mr. Weinmann worked as an Executive Director in Morgan Stanley’s Global Capital Markets division, specializing in healthcare debt financings and intellectual property monetizations. Over the course of his career, Mr. Weinmann has closed in excess of $20 billion of debt and equity financings and an additional $10 billion of M&A transactions.

Mr. Weinmann received a Bachelor of Science in chemical engineering in 1999 from the Johns Hopkins University, graduating first in a class of 770.

David Carter is a member of CRG’s Founders Group and serves as Partner. Mr. Carter joined CRG in 2003 and has more than 25 years of investment and advisory experience.

David Carter

Partner

David Carter is a member of CRG’s Founders Group and serves as Partner. Mr. Carter joined CRG in 2003 and has more than 25 years of investment and advisory experience. Mr. Carter leads the due diligence efforts related to CRG’s investments in the medical device, specialty pharma, drug delivery, biopharma and tools & diagnostic sectors. Mr. Carter, in addition to focusing on sourcing, execution and monitoring existing CRG investments is responsible for staffing CRG deal teams. Prior to joining CRG, Mr. Carter was a partner at Palestra Capital, a hedge fund focused on risk arbitrage and special situations. Before joining Palestra, Mr. Carter was a high yield analyst at Furman Selz LLC, where he was responsible for coverage of healthcare-related high yield debt. Previously, Mr. Carter was an investment banking analyst in the Healthcare Group at Chemical Bank and a research assistant in the Mergers & Acquisitions Group of Morgan Stanley. Over the course of his career, Mr. Carter has closed in excess of $5 billion of financing activity.

Mr. Carter received a Bachelor of Science in finance from The Pennsylvania State University in 1988. He received a Master of Arts degree in information science and systems in 1994 and an M.B.A. in 1996, both from Columbia University.

Andrei Dorenbaum is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen and General Counsel.

Andrei Dorenbaum

General CounselPartner, Piedmont Evergreen

Andrei Dorenbaum is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen and General Counsel. Mr. Dorenbaum joined CRG in 2010 and is responsible for managing the legal function of the firm’s investment and financing activities. This includes structuring investments, identifying underwriting risks during diligence and negotiating terms. In addition, he supports the structuring and negotiation of the funds’ financing facilities with banks and other financing counter parties. He is also responsible for managing bankruptcies and contested workouts. Mr. Dorenbaum manages operations in the Houston office and oversees the operation of CRG’s back-office and accounting group. Prior to joining CRG, Mr. Dorenbaum was an assistant general counsel at Highland Capital where he completed over $2 billion in negotiated investments and structured derivative financing arrangements.

Mr. Dorenbaum received a B.A. (magna cum laude) in applied economics and J.D. (cum laude) both from the University of Michigan. He also earned an LL.M. from Georgetown University School of Law.

Scott Li joined CRG in 2015 and is a Managing Director. Mr. Li has been focused on the healthcare industry as an advisor, investor and executive for over 15 years.

Scott Li

Managing Director

Scott Li joined CRG in 2015 and is a Managing Director. Mr. Li has been focused on the healthcare industry as an advisor, investor and executive for over 15 years. Mr. Li helps leads investment sourcing, diligence, and execution for CRG activity in various sectors, including healthcare services and specialty pharma.

Prior to joining CRG, Mr. Li was an investment banker with Hammond Hanlon Camp LLC (“H2C”). Mr. Li’s previous investment banking experience also includes positions in the Life Sciences Investment Banking Group of Lazard and the North American M&A Group of J.P. Morgan. Prior to joining H2C, Mr. Li was the Chief Financial Officer of pingmd, a provider of an online communication platform for primary care physicians. Mr. Li was also previously an Associate with ABS Ventures, the venture capital arm of DB Capital Partners. Mr. Li. received an AB in economics from Princeton University in 1997 and an M.B.A from the Wharton School at the University of Pennsylvania in 2004.

Todd Holmes joined CRG in 2018 and serves as a Principal. Todd brings to CRG nearly 15 years of investing, company building and transaction experience across private and public sectors.

Todd Holmes

Principal

Todd Holmes joined CRG in 2018 and serves as a Principal. Todd brings to CRG 15 years of investing, company building and transaction experience across private and public sectors. Mr. Holmes leads investment sourcing, diligence and execution for CRG activity in various sectors including specialty pharma, medical technology and healthcare services.

Prior to joining CRG, Todd was an investor and founding member of Gurnet Point Capital. There he led investments and acquisitions across multiple stages and sectors within healthcare and was actively involved on company boards as well as in portfolio company operations.

Previously, Mr. Holmes was a member of Third Rock Ventures where he held investment and operational roles and was part of the founding team at Ember Therapeutics. Earlier in his career, Todd was an investor at BVF Partners, a biotechnology-focused hedge fund, and a member of the commercial lending practice at Silicon Valley Bank.

Mr. Holmes received a Bachelor's degree in Economics from Colgate University and an MBA from the Wharton School at the University of Pennsylvania.

Adam Whitehead joined CRG in 2016, bringing over 10 years of experience in asset allocation, manager due diligence and fundraising.

Adam Whitehead

Vice President

Adam Whitehead joined CRG in 2016, bringing over 10 years of experience in asset allocation, manager due diligence and fundraising. Mr. Whitehead is part of CRG’s Investor Relations team, responsible for raising capital and client service. Previously, Mr. Whitehead was a senior investment analyst at Crestone Capital Advisors, a large multi-family office. Mr. Whitehead has held research and trading roles at Quantitative Equity Systems, Sovereign Wealth Management, Warwick Capital Management, The Bornhoft Group and Branch Banking & Trust.

Mr. Whitehead graduated from St. Andrews Presbyterian College, magna cum laude, in Laurinburg, North Carolina with a major in business (emphasis in finance and accounting).

Zain Shekhani joined CRG in 2013 and is a member of the Investment Team. Mr. Shekhani’s focuses include identifying and assessing new investment opportunities, due diligence efforts before making...

Zain Shekhani

Vice President

Zain Shekhani joined CRG in 2013 and is a member of the Investment Team. Mr. Shekhani’s focuses include identifying and assessing new investment opportunities, due diligence efforts before making portfolio companies investments, and servicing and monitoring portfolio companies post-investment. Additionally, Mr. Shekhani supports the firm’s investor relations and capital raising efforts. Prior to CRG, Mr. Shekhani was an analyst with Stifel's Healthcare Investment Banking Group.

Mr. Shekhani graduated magna cum laude from the Stern School of Business at New York University with a Bachelor of Science in Finance and Economics.

Kevin Reilly joined CRG in 2014 and is a member of the Investment Team. Mr. Reilly’s primary focus is identifying and assessing new investment opportunities, due diligence efforts before making...

Kevin Reilly

Vice President

Kevin Reilly joined CRG in 2014 and is a member of the Investment Team. Mr. Reilly’s primary focus is identifying and assessing new investment opportunities, due diligence efforts before making portfolio companies investments, and servicing and monitoring portfolio companies post-investment. Mr. Reilly has been particularly active within medical devices, amongst other healthcare sectors. Mr. Reilly also spends time on the capital-raising side of the business including helping to manage CRG’s leverage strategy. Prior to CRG, Mr. Reilly was an analyst with Stifel’s Healthcare Investment Banking Group.

Mr. Reilly graduated from the Robert H. Smith School of Business at the University of Maryland with a Bachelor of Science in Finance and Information Systems.

Kris Talgo joined CRG in 2015 and serves as an Associate on the Investment Team.

Kris Talgo

Associate

Kris Talgo joined CRG in 2015 and serves as an Associate on the Investment Team. Mr. Talgo’s primary focus is identifying and assessing new investment opportunities, due diligence efforts before making portfolio company investments, and servicing and monitoring portfolio companies post-investment. Mr. Talgo has focused largely within specialty pharmaceuticals and biopharmaceuticals, amongst other healthcare sectors. Prior to CRG, Mr. Talgo was an analyst with Leerink Partners’ Investment Banking Group.

Mr. Talgo graduated with honors from Lehigh University with a Bachelor of Science in Finance and Accounting.

Stanley Twarog joined CRG in 2016 and serves as an Associate on the Investment Team.

Stanley Twarog

Associate

Stanley Twarog joined CRG in 2016 and serves as an Associate on the Investment Team. Mr. Twarog’s primary focuses are identifying, assessing, and executing new investment opportunities as well as monitoring existing portfolio investments. Prior to CRG, Mr. Twarog served in a financial operations role at Surgical Care Affiliates, a leading outpatient ambulatory surgical care company. Prior to joining Surgical Care Affiliates, Mr. Twarog was an analyst at Hammond Hanlon Camp, a healthcare focused strategic advisory and investment banking firm.

Mr. Twarog graduated cum laude from Vanderbilt University with a B.A. in Economics.

Noah Putter joined CRG in 2016 and serves as an Analyst on the Investment Team.

Noah Putter

Analyst

Noah Putter joined CRG in 2016 and serves as an Analyst on the Investment Team. Mr. Putter’s primary focuses are identifying, assessing, and executing new investment opportunities as well as monitoring existing portfolio investments. Mr. Putter also works on executing CRG’s leverage strategy, helping to raise and manage debt financing at the fund level. Prior to CRG, Mr. Putter was an analyst with Leerink Partners’ Investment Banking Group.

Mr. Putter graduated with high distinction from the University of Michigan’s Ross School of Business with a Bachelor of Business Administration

Ben Wessner joined CRG in 2017 and serves as an Analyst on the Investment Team.

Ben Wessner

Analyst

Ben Wessner joined CRG in 2017 and serves as an Analyst on the Investment Team. Mr. Wessner’s primary focuses are identifying, assessing, and executing new investment opportunities as well as monitoring existing portfolio investments. Prior to CRG, Mr. Wessner was an analyst with Piper Jaffray’s Healthcare Investment Banking Group.

Mr. Wessner graduated from the Charles H. Dyson School at Cornell University with a Bachelor of Science in Applied Economics and Management.

Erica Palestrini joined CRG in 2014 and is the Operations Manager. In addition to working with the Investor Relations Team, she supports Mr. Hukill on special projects, employee education and...

Erica Palestrini

Operations Manager & Investor Relations

Erica Palestrini joined CRG in 2014 and is the Operations Manager. In addition to working with the Investor Relations Team, she supports Mr. Hukill on special projects, employee education and training and strategic planning. Ms. Palestrini organizes and plans investment training in detection of deception and elicitation and other disciplines for CRG’s investment staff, as well as plans and manages the firm’s annual meeting of Limited Partners. Ms. Palestrini is also responsible for managing CRG’s administrative team.

Ms. Palestrini has held various operational support positions with various international companies including the Allen & Overy Law Firm in Singapore, Olswang Law Firm in London, and Air New Zealand in Auckland, New Zealand.

Ava Lee joined CRG in 2017 and serves as an Analyst on the Investor Relations team.

Ava Lee

Analyst

Ava Lee joined CRG in 2017 and serves as an Analyst on the Investor Relations team. Ms. Lee works closely with the Investments and Finance team to manage and fulfill information requests on behalf of the firm’s investors. Ms. Lee also supports the firm’s capital raising efforts through the creation of marketing materials and investor reports for current and prospective investors.

Prior to joining CRG, Ms. Lee was an Associate in Citadel's Client & Partner Group. Ms. Lee started off her career in investment banking at the Royal Bank of Canada.

Ms. Lee graduated cum laude from the University of Notre Dame with a Bachelor of Science in Finance and Political Science.

Andrei Dorenbaum is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen and General Counsel.

Andrei Dorenbaum

General CounselPartner, Piedmont Evergreen

Andrei Dorenbaum is a member of CRG’s Founders Group and serves as Partner at Piedmont Evergreen and General Counsel. Mr. Dorenbaum joined CRG in 2010 and is responsible for managing the legal function of the firm’s investment and financing activities. This includes structuring investments, identifying underwriting risks during diligence and negotiating terms. In addition, he supports the structuring and negotiation of the funds’ financing facilities with banks and other financing counter parties. He is also responsible for managing bankruptcies and contested workouts. Mr. Dorenbaum manages operations in the Houston office and oversees the operation of CRG’s back-office and accounting group. Prior to joining CRG, Mr. Dorenbaum was an assistant general counsel at Highland Capital where he completed over $2 billion in negotiated investments and structured derivative financing arrangements.

Mr. Dorenbaum received a B.A. (magna cum laude) in applied economics and J.D. (cum laude) both from the University of Michigan. He also earned an LL.M. from Georgetown University School of Law.

Garth Monroe joined CRG in March 2014 as Chief Financial Officer. He is responsible for accounting, tax, treasury, human resources, information technology, and risk management.

Garth Monroe

Chief Financial Officer

Garth Monroe joined CRG in March 2014 as Chief Financial Officer. He is responsible for accounting, tax, treasury, human resources, information technology, and risk management. Keeping pace with CRG’s growth, the accounting team has expanded from two to six professionals during his tenure. The team produces quarterly financial statements, annual federal and state tax returns, K-1s, and answers LP requests.

Prior to joining the firm, he was Vice President and CFO at both BioNano Genomics and Epocal, two early-stage biotechnology companies. Mr. Monroe started his career working for United Technologies and JetBlue Airways; he also served in the U.S. Marine Corps.

Mr. Monroe is a CPA (inactive), and graduated summa cum laude from the University of Connecticut with a Bachelor of Science in Business Administration. He earned an MBA from the University of Virginia, Darden School of Business.

Courtney Grobe joined CRG in 2005 and serves as Vice President & Controller. Ms. Grobe’s responsibilities include overseeing the accounting and reporting of the firm’s private equity funds under...

Courtney Grobe

Vice President & Controller

Courtney Grobe joined CRG in 2005 and serves as Vice President & Controller. Ms. Grobe’s responsibilities include overseeing the accounting and reporting of the firm’s private equity funds under management, including over 20 investment vehicles and an SBIC. In addition, she manages the audit engagements and supervises two fund administrators. Prior to joining CRG, Ms. Grobe worked as an audit professional at Deloitte & Touche, where her two largest clients were in the manufacturing and healthcare industries.

Ms. Grobe graduated magna cum laude from Texas A&M University receiving a Bachelor of Business Administration, specializing in accounting. Ms. Grobe also earned a Masters degree in Accounting from Texas A&M University and is a CPA.

Colin Eckersley joined CRG in 2014 and serves as Assistant Controller. Mr. Eckersley is responsible for fund accounting, reporting, and compliance for Fund I and CRG’s SBIC.

Colin Eckersley

Assistant Controller

Colin Eckersley joined CRG in 2014 and serves as Assistant Controller. Mr. Eckersley is responsible for fund accounting, reporting, and compliance for Fund I and CRG’s SBIC. Additionally, Mr. Eckersley is in charge of the onboarding and subscription process for Fund IV. Prior to joining CRG, Mr. Eckersley held an accounting position at a small sales company.

Mr. Eckersley is a licensed CPA and graduated from the C.T. Bauer College of Business at the University of Houston with a Bachelor of Business Administration, specializing in accounting. Mr. Eckersley also earned a Masters degree in Accounting from the University of Houston.

Stephanie Divin joined CRG in 2016 and serves as Assistant Controller. Ms. Divin is responsible for the fund accounting for Funds II and Fund III.

Stephanie Divin

Assistant Controller

Stephanie Divin joined CRG in 2016 and serves as Assistant Controller. Ms. Divin is responsible for the fund accounting for Funds II and Fund III. Additionally, Ms. Divin is in charge of the compliance and reporting for the Fund II and Fund III securitization transactions and other leverage facilities. Prior to joining CRG, Stephanie worked as an assurance professional at PricewaterhouseCoopers. Stephanie was in the Private Client Service group with clients in higher education, healthcare and manufacturing.

Stephanie is a licensed CPA and graduated from the McCombs School of Business at the University of Texas with a Bachelors of Business Administration and a Masters in Professional Accountancy.

Jonathan Gay joined CRG in 2017 and serves as Senior Accountant. Mr. Gay is responsible for manager accounting and financials, accounts payable, and facilitating LP and portfolio company customer...

Jonathan Gay

Senior Accountant

Jonathan Gay joined CRG in 2017 and serves as Senior Accountant. Mr. Gay is responsible for manager accounting and financials, accounts payable, and facilitating LP and portfolio company customer service requests. Prior to joining CRG, Mr. Gay worked as an audit professional at Ernst & Young, with clients in the sports entertainment, manufacturing, and automotive industries.

Mr. Gay is a licensed CPA and graduated magna cum laude from Lamar University, with a Bachelors of Business Administration and a Masters of Science in Accounting.

Charles Tate is Chairman Emeritus of CRG. He has over 50 years’ experience in investment banking, merchant banking, and private equity.

Charles Tate

Chairman Emeritus

Charles Tate is Chairman Emeritus of CRG. He has over 50 years’ experience in investment banking, merchant banking, and private equity. Prior to forming CRG, Mr. Tate was a Partner and Member of the Management Committee of Hicks, Muse, Tate & Furst Incorporated from 1991 until June 2002. After starting his career at Bank of America in New York, he worked at Morgan Stanley & Co. for 19 years, mostly as a Managing Director in the Mergers and Acquisitions Department.

Mr. Tate received his B.B.A. from The University of Texas at Austin in 1968. He was inducted into The University of Texas at Austin McCombs School of Business Hall of Fame in 2003, was named Distinguished Alumnus of The University of Texas in 2007 and also received The University of Texas at Austin 2011-2012 Presidential Citation in recognition of his leadership, sustained commitment, and service to The University.

Additionally, Mr. Tate received his M.B.A. from Columbia University Graduate School of Business in 1972 and has been a Member of its Board of Overseers since 2001.

Phil Houston is a nationally recognized authority on deception detection, critical interviewing, and elicitation. His 25 year career with the Central Intelligence Agency was highlighted by his...

Phil Houston

Senior Advisor

Phil Houston is a nationally recognized authority on deception detection, critical interviewing, and elicitation. His 25 year career with the Central Intelligence Agency was highlighted by his service as a senior member of the Office of Security. In that capacity he conducted thousands of interviews and interrogations for the CIA and other federal agencies, both as an investigator and as a polygraph examiner. He is credited with developing a detection of deception methodology currently employed throughout the U.S. intelligence and federal law enforcement communities. Mr. Houston introduced the detection of deception methodology to the corporate world with the co-founding of Business Intelligence Advisors, where he served as Executive Vice President.

Mr. Houston holds a B.A. in Political Science from East Carolina University in Greenville, N.C.

Mark McClellan is the Director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business, Medicine and Health Policy at Duke University.

Mark McClellan, MD, PhD

Senior Advisor

Mark McClellan is the Director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business, Medicine and Health Policy at Duke University. Prior to this, Mark was a Senior Fellow and Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. His work focuses on strategies and policy reforms to improve health care, including such areas as accountable care, better evidence from real-world practice, and more effective drug and device innovation. A doctor and economist by training, he also has a highly distinguished record in public service and in academic research. Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care.

Dr. McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the FDA, is co-chair of the Quality Alliance Steering Committee, chairs the National Quality Forum’s partnership on clinician quality measurement, is a member of the Institute of Medicine, and is a research associate at the National Bureau of Economic Research. He has also served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House, and as Deputy Assistant Secretary for Economic Policy at the Department of the Treasury. He was previously an associate professor of economics and medicine with tenure at Stanford University, and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.

Harlan Weisman, MD

Senior Advisor

Harlan F. Weisman, M.D. is the founder and Managing Director of And-One Consulting, LLC, advising medical product companies, investment firms, and government and non-government healthcare organizations in formulating and implementing successful strategies for driving innovation in healthcare products and services. He is co-founder, Board Director and Chief Scientific Officer for Mycrobiomics, Inc. and Executive Chairman of 3DBio Corp. He is also on the board of directors of ControlRad Systems, Inc and Hutchison Biofilm Medical Solutions Ltd, and is an advisor to the Israel Biotechnology Fund, the Johns Hopkins Institute for Basic Biomedical Sciences, Memorial Sloan Kettering Cancer Center and BioMotiv, a medical product accelerator company.

Previously, Dr. Weisman was Chairman and CEO of Coronado Biosciences, Inc., a company focused on developing treatments for immune mediated inflammatory disorders. Prior to Coronado, he served over 20 years as a senior executive at Johnson & Johnson including as Chief Science and Technology Officer of the J&J Medical Devices Group, Company Group Chairman, J&J Pharmaceutical Research & Development, President of Centocor R&D and also served on the board of directors of J&J Development Corporation (JJDC). Before joining industry, Dr. Weisman was Assistant Professor of Medicine and Director of the Experimental Cardiac Pathology Laboratory at the Johns Hopkins University School of Medicine, and Consultant Cardiologist at Johns Hopkins Hospital.

Dr. Weisman has authored more than 100 articles and book chapters about cardiovascular disease, medical product development, healthcare policy and organizational development. He is a frequent invited speaker at international meetings on medical innovation, health policy and product development strategy.